Samuel Shapiro

Summary

Affiliation: Columbia University
Country: USA

Publications

  1. ncbi Adverse neoplastic and cardiovascular outcomes of HRT: the validity of the evidence
    Samuel Shapiro
    Slone Epidemiology Centre, Boston University, MA, USA
    Endocrine 24:203-10. 2004
  2. ncbi Risk of invasive cancer of the cervix in relation to the use of injectable progestogen contraceptives and combined estrogen/progestogen oral contraceptives (South Africa)
    Samuel Shapiro
    Department of Epidemiology, Mailman School of Public Health, Columbia University, 600 West 168th Street PH 18 106, New York, NY 10032, USA
    Cancer Causes Control 14:485-95. 2003
  3. ncbi Hypothesis: the act of taking a Papanicolaou smear reduces the prevalence of human papillomavirus infection: a potential impact on the risk of cervical cancer
    Samuel Shapiro
    Columbia University, USA
    Cancer Causes Control 14:953-7. 2003
  4. ncbi Cervical human papillomavirus (HPV) infection in South African women: implications for HPV screening and vaccine strategies
    Bruce Allan
    Institute of Infectious Disease and Molecular Medicine and Division of Medical Virology, Department of Clinical Laboratory Sciences, Faculty of Health Sciences, University of Cape Town, Observatory, Cape Town, South Africa
    J Clin Microbiol 46:740-2. 2008
  5. ncbi Determinants of sexual activity and its relation to cervical cancer risk among South African women
    Diane Cooper
    Women s Health Research Unit, School of Public Health and Family Medicine, Faculty of Health Sciences, University of Cape Town, Anzio Road, Observatory, 7925, Cape Town, South Africa
    BMC Public Health 7:341. 2007
  6. ncbi Papanicolaou smears induce partial immunity against sexually transmitted viral infections
    Samuel Shapiro
    Department of Public Health and Family Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa
    Epidemiology 18:709-15. 2007
  7. ncbi Oral oestrogen-progestagen contraceptives, menopausal treatment, and cancer
    Samuel Shapiro
    Lancet Oncol 6:736; author reply 737. 2005
  8. ncbi HIV and pre-neoplastic and neoplastic lesions of the cervix in South Africa: a case-control study
    Jennifer R Moodley
    School of Public Health and Family Medicine, Women s Health Research Unit, University of Cape Town, 7925, South Africa
    BMC Cancer 6:135. 2006
  9. ncbi The Million Women Study: potential biases do not allow uncritical acceptance of the data
    Samuel Shapiro
    Climacteric 7:3-7. 2004
  10. ncbi Risk factors for breast cancer in South African women
    Lynn Rosenberg
    S Afr Med J 92:447-8. 2002

Collaborators

Detail Information

Publications22

  1. ncbi Adverse neoplastic and cardiovascular outcomes of HRT: the validity of the evidence
    Samuel Shapiro
    Slone Epidemiology Centre, Boston University, MA, USA
    Endocrine 24:203-10. 2004
    ....
  2. ncbi Risk of invasive cancer of the cervix in relation to the use of injectable progestogen contraceptives and combined estrogen/progestogen oral contraceptives (South Africa)
    Samuel Shapiro
    Department of Epidemiology, Mailman School of Public Health, Columbia University, 600 West 168th Street PH 18 106, New York, NY 10032, USA
    Cancer Causes Control 14:485-95. 2003
    ..Cervical cancer is caused by specific types of the human papilloma virus (HPV), but not all infected women develop cancer. It has been hypothesized that hormonal contraceptives may potentiate the oncogenicity of HPV infection...
  3. ncbi Hypothesis: the act of taking a Papanicolaou smear reduces the prevalence of human papillomavirus infection: a potential impact on the risk of cervical cancer
    Samuel Shapiro
    Columbia University, USA
    Cancer Causes Control 14:953-7. 2003
    ..We hypothesized that the act of performing a Pap smear may trigger an immune response to human papillomavirus (HPV) infection and thus reduce the risk of cervical cancer...
  4. ncbi Cervical human papillomavirus (HPV) infection in South African women: implications for HPV screening and vaccine strategies
    Bruce Allan
    Institute of Infectious Disease and Molecular Medicine and Division of Medical Virology, Department of Clinical Laboratory Sciences, Faculty of Health Sciences, University of Cape Town, Observatory, Cape Town, South Africa
    J Clin Microbiol 46:740-2. 2008
    ..HPV types 16 and 35 were the dominant types in women with HSILs but not in women in the other categories...
  5. ncbi Determinants of sexual activity and its relation to cervical cancer risk among South African women
    Diane Cooper
    Women s Health Research Unit, School of Public Health and Family Medicine, Faculty of Health Sciences, University of Cape Town, Anzio Road, Observatory, 7925, Cape Town, South Africa
    BMC Public Health 7:341. 2007
    ..Invasive cervical cancer is the commonest cause of cancer morbidity and mortality in South African women. This study provides information on adult women's sexual activity and cervical cancer risk in South Africa...
  6. ncbi Papanicolaou smears induce partial immunity against sexually transmitted viral infections
    Samuel Shapiro
    Department of Public Health and Family Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa
    Epidemiology 18:709-15. 2007
    ..Here we assess the risk of 3 sexually transmitted viral infections -- herpes simplex virus 2 (HSV2), HPV, and human immunodeficiency virus (HIV) 1 and 2 -- in relation to the lifetime receipt of Pap smears...
  7. ncbi Oral oestrogen-progestagen contraceptives, menopausal treatment, and cancer
    Samuel Shapiro
    Lancet Oncol 6:736; author reply 737. 2005
  8. ncbi HIV and pre-neoplastic and neoplastic lesions of the cervix in South Africa: a case-control study
    Jennifer R Moodley
    School of Public Health and Family Medicine, Women s Health Research Unit, University of Cape Town, 7925, South Africa
    BMC Cancer 6:135. 2006
    ..The aim of this study was to determine the risk of cervical pre-cancer and cancer among HIV positive women in South Africa...
  9. ncbi The Million Women Study: potential biases do not allow uncritical acceptance of the data
    Samuel Shapiro
    Climacteric 7:3-7. 2004
    ....
  10. ncbi Risk factors for breast cancer in South African women
    Lynn Rosenberg
    S Afr Med J 92:447-8. 2002
  11. ncbi Oral contraceptives, menopausal treatment, and cancer
    Samuel Shapiro
    Lancet Oncol 8:867; author reply 867-8. 2007
  12. ncbi Cervical human papillomavirus (HPV) infection and HPV type 16 antibodies in South African women
    Dianne J Marais
    Institute of Infectious Disease and Molecular Medicine and Division of Medical Virology, Department Clinical Laboratory Sciences, Faculty of Health Sciences, University of Cape Town, Observatory, Cape Town, South Africa
    J Clin Microbiol 46:732-9. 2008
    ..6). High levels of exposure to HPV, and particularly HPV-16, were evident in this population. The apparent increase of serum HPV-16 IgA with increasing age requires further investigation...
  13. ncbi Causation, bias and confounding: a hitchhiker's guide to the epidemiological galaxy. Part 1. Principles of causality in epidemiological research: time order, specification of the study base and specificity
    Samuel Shapiro
    Department of Epidemiology, University of Cape Town, Cape Town, South Africa
    J Fam Plann Reprod Health Care 34:83-7. 2008
  14. ncbi Causation, bias and confounding: a hitchhiker's guide to the epidemiological galaxy Part 2. Principles of causality in epidemiological research: confounding, effect modification and strength of association
    Samuel Shapiro
    Department of Epidemiology, University of Cape Town, Cape Town, South Africa
    J Fam Plann Reprod Health Care 34:185-90. 2008
  15. ncbi Hormone therapy and cardiovascular risk
    Samuel Shapiro
    JAMA 298:623; author reply 624-5. 2007
  16. ncbi The agreement between cervical abnormalities identified by cytology and detection of high-risk types of human papillomavirus
    Bruce R Allan
    Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, South Africa
    S Afr Med J 96:1186-90. 2006
    ..When costs decrease, HC2 could be introduced as an adjunct to Pap smears in identifying women at risk for high-grade cervical disease and could be useful in the maintenance of cervical health in those who remain Pap smear negative...
  17. ncbi Statin use and the risk of breast and prostate cancer
    Patricia F Coogan
    Slone Epidemiology Unit, Boston University School of Medicine, Brookline, MA 02446, USA
    Epidemiology 13:262-7. 2002
    ..In the present study, we assessed the relation of statin use to the risk of breast and prostate cancer in our hospital-based Case-Control Surveillance Study of Drugs and Serious Illnesses...
  18. ncbi Non-contrast-enhanced computerized tomography and analgesic-related kidney disease: report of the national analgesic nephropathy study
    William L Henrich
    Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA
    J Am Soc Nephrol 17:1472-80. 2006
    ..Findings of SICK are infrequent in the US ESRD population and do not occur among a sufficient proportion of heavy analgesic users to render the non-contrast-enhanced CT scan a sensitive tool to detect analgesic-associated kidney injury...
  19. ncbi The epidemiology of aplastic anemia in Thailand
    Surapol Issaragrisil
    Division of Hematology, Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand
    Blood 107:1299-307. 2006
    ....
  20. ncbi Case-control studies of screening should carry a health warning. Response
    Margaret Hoffman
    Int J Epidemiol 32:1112. 2003
  21. ncbi Estrogen replacement therapy and risk of lung cancer
    Janine A Blackman
    Department of Family Practice, Franklin Square Hospital Center, Baltimore, MD, USA
    Pharmacoepidemiol Drug Saf 11:561-7. 2002
    ..There were non-significant increases for non-small cell types other than squamous, but there was no consistent pattern across duration of use. CONCLUSION: Our data do not support an increased risk of lung cancer among women who use ERT...
  22. ncbi Re: "Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study"
    Samuel Shapiro
    Am J Epidemiol 168:1213; author reply 1213-4. 2008